RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nuventra Pharma Sciences, a specialty pharmaceutical consulting firm with global reach, today announced the opening of its expanded corporate headquarters in Research Triangle Park, North Carolina as well as the opening of new regional offices in both the Greater Philadelphia area and in Wilmington, N.C.
The new offices will accommodate an expanding workforce and capitalize on the increased demand by pharmaceutical and biotech companies for Nuventra’s clinical pharmacology, pharmacokinetic, and pharmacometric (population PK) expertise.
“This represents the latest chapter in our growth strategy,” said Geoffrey Banks, Ph.D., Nuventra’s President and CEO, adding further, “Our workforce has doubled over the past year and Nuventra will continue to add senior pharmacokinetic consultants along with the infrastructure to support them.”
Although Nuventra serves clients globally, the new regional offices will offer a greater level of service to a growing client base and provide better access to both prospective clients and a skilled and experienced talent pool.
“Nuventra’s growth in pharmacometrics/population PK contributed to a strong 2013,” said M. Alexander Shaw, Ph.D., Nuventra’s COO, adding further, “We expect 2014 to be another great year as we continue adding depth to our team and physical presence in key pharmaceutical / biotech hotspots around the globe.”
About Nuventra Pharma Sciences
Founded in 2008, Nuventra is the pharmaceutical industry’s go-to resource for clinical pharmacology, pharmacokinetic, and pharmacometric consulting services. Nuventra gives pharmaceutical companies and CROs rare access to a hands-on team of industry-leading consultants experienced in complex studies and analyses. We embrace the notion that simplicity and clarity lead to good decisions by taking complex pharmacokinetic and pharmacometric principals and making them understandable and usable for common sense drug development. Nuventra’s flexible business structure enables us to integrate with our clients and help them maximize the potential of clinical pharmacology studies and pharmacokinetic analyses to pave the way toward marketing approval. For more information, visit www.nuventra.com.
